The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.
about
Pathogenesis of human immunodeficiency virus infectionIncreasing clinical virulence in two decades of the Italian HIV epidemicPhylogenetic approach reveals that virus genotype largely determines HIV set-point viral loadHIV and the returning expatriate.HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.Universal WBC reduction: the case for and against.Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.Use of blood donation history of people with HIV infection to identify recipients at risk.Estimating per-act HIV transmission risk: a systematic review.Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.Nitrite inhalants: history, epidemiology, and possible links to AIDS.Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivoPrimary infection by type 1 human immunodeficiency virus: diagnosis and prognosisTrends in incidence of AIDS associated with transfusion of blood and blood products in Europe and the United States, 1985-93HIV-1 Nef: at the crossroadsMechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.Diagnosing acute HIV infection.Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection.A strong case for viral genetic factors in HIV virulence.Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.Characteristics of acquired immunodeficiency syndrome in older adults.Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.Human immunodeficiency virus infection in children who received transfusions in Mexico.Long-term survival in HIV-1 infection.T4+ cell depletion as a major risk factor for AIDS-related complex and AIDS. Longitudinal study of 253 HIV-antibody positive heroin addicts from northern Italy.Long-term survival in transfusion recipients in Sweden, 1993.Partner notification for human immunodeficiency virus infection in Colorado: results across index case groups and costs.AIDS: safety, regulation and the law in procedures using blood and blood products.Four-year survival of transfusion recipients identified by hepatitis C lookback.Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990
P2860
Q24634681-41096FBA-F91A-481B-BA33-7F62CCE1FDA4Q28475522-E0620084-CF8D-4567-825C-53399E75F03DQ28475652-E10274E3-CECE-4B73-8A4B-A0659240CAAAQ33669671-FF1B8AC9-DF25-428B-8648-CE9C302608CDQ33742029-662E1202-34A2-4741-A6AA-ECCA703C59D4Q34247853-96EABD23-B39B-415F-9A81-EB04C3BF0F3DQ34276456-F1BEC91F-1977-4FBF-A224-62F43E2B13F8Q34277491-3AE7F967-77CE-41F7-AF0A-3FED4441C369Q34661804-FA51CFD7-9D8C-4B43-8814-A04039620B0CQ34949513-D59A8F97-D487-4F09-939F-C9372EA7D947Q35032251-F59B51A5-486D-47DE-A357-E2AA935BBE23Q35181236-EA4784B1-A88C-4264-8A83-D775A0ED2180Q35841911-405FFFB0-9434-494D-B46E-1F4C9312E8DFQ36727980-831B780A-6310-443B-8B50-1CFFAC6CE9BDQ36901279-6B8577D0-FFC6-4F05-AB6C-D08FB2B0D651Q36926697-575E35B9-80F3-4A44-A84D-CDF9AD01E3C7Q37078512-7144FA51-3505-4398-B407-F2FB9B92050FQ37965692-AE0015B4-9597-4463-8ADD-AB8E5F1DC74FQ38039219-FF393AC4-5DCC-4B7C-8C98-12B70F470187Q38615326-61D76A88-B9E5-43C4-BDD9-11BB5FE8940EQ39439717-1F822C41-5BC3-4223-A34A-6FC3E113B092Q40915887-CE3E723B-57F7-4044-AC6A-3CE678AE7684Q41706811-A8835CD0-65B0-46AF-A7AD-DE307701B59BQ42280789-6908A973-A65F-413C-946B-F62F7E64A79DQ42543298-113B8ADB-D040-47F0-9A62-A54CCE53F110Q42591910-D2D175F7-BF77-4DE6-9FB5-4F537EDB52DEQ43669317-BCD08A21-E179-424D-A42A-3FEE28FB9E93Q44681875-22914DEF-731B-4C75-96F5-4155DF143110Q45774074-D1150825-1C91-40DA-BFD5-3115FAB41316Q45883125-49E2FEE5-A0FB-4012-9150-820422CE6B86Q50110000-57D23BC4-7FD6-4B68-BF86-8A6F6463A2E5Q57695982-EC1B98B0-8124-44E4-B086-EE95E9A26F39
P2860
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The natural history of transfu ...... ate of progression to disease.
@ast
The natural history of transfu ...... ate of progression to disease.
@en
The natural history of transfu ...... ate of progression to disease.
@nl
type
label
The natural history of transfu ...... ate of progression to disease.
@ast
The natural history of transfu ...... ate of progression to disease.
@en
The natural history of transfu ...... ate of progression to disease.
@nl
prefLabel
The natural history of transfu ...... ate of progression to disease.
@ast
The natural history of transfu ...... ate of progression to disease.
@en
The natural history of transfu ...... ate of progression to disease.
@nl
P2093
P1476
The natural history of transfu ...... ate of progression to disease.
@en
P2093
Fernando LP
Goldfinger D
Holland PV
Pepkowitz SH
Perkins HA
P304
P356
10.1056/NEJM198910053211406
P407
P577
1989-10-01T00:00:00Z